生物活性 | |||
---|---|---|---|
描述 | Dinoprost tromethamine salt, also known as Prostaglandin F2α tromethamine salt, is a potent agonist of the prostaglandin F (PGF) receptor (FP receptor) that can be administered orally. It acts as a luteolytic hormone primarily synthesized in the endometrial luminal epithelium and corpus luteum (CL). Dinoprost tromethamine salt plays a pivotal role in initiating and advancing labor [1][2]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02052908 | Lynch Syndrome | Phase 1 | Active, not recruiting | - | United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 收起 << |
NCT01974674 | Patients With Type 1 Diabetes | Phase 2 | Recruiting | January 2022 | France ... 展开 >> Saint Louis hospital Recruiting Paris, Ile de France, France, 75010 Contact: Pierre CATTAN, MD PhD 33 1 42494786 pierre.cattan@sls.aphp.fr 收起 << |
NCT01688154 | Triglyceride Metabolism ... 展开 >> Cardiovascular Function 收起 << | Not Applicable | Completed | - | Spain ... 展开 >> CTNS Reus, Tarragona, Spain, 43204 Technological Center of Nutrition and Health (CTNS) Reus, Tarragona, Spain, 43204 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.10mL 0.42mL 0.21mL |
10.51mL 2.10mL 1.05mL |
21.03mL 4.21mL 2.10mL |
参考文献 |
---|